INOVIO PHARMACEUTICALS, INC. Prepaid Expense and Other Assets, Current
INOVIO PHARMACEUTICALS, INC. (INO) had Prepaid Expense and Other Assets, Current of $3.24 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $3.24M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.76M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $2.61M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.40M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.24M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.76M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.61M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.40M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $4.31M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.22M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.72M 10-K · filed 2026-03-12 | $2.52M 10-K · filed 2025-03-18 |
| 2024-09-30 | $4.62M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $5.37M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.52M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $5.41M 10-K · filed 2025-03-18 | $5.39M 10-K · filed 2024-03-06 |
| 2023-09-30 | $5.11M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.91M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $50.13M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $57.97M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $56.26M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $31.95M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $38.84M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $85.33M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $84.59M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $59.57M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $40.36M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $31.56M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.59M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.48M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.58M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $1.68M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.31M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.39M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.41M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $1.60M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.79M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.60M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $4.54M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.91M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $4.21M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.75M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $1.39M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.19M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.12M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $917.26K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $1.35M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $551.30K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $657.66K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $797.97K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $542.01K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $673.89K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $464.09K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $637.43K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $471.87K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $710.29K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $283.04K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $471.33K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $487.72K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $598.48K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $760.73K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $746.05K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $866.03K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $822.23K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $273.98K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |